Cidofovir Injection 375mg/5mL (75mg/mL) vial injection. 5 mL vials, Rx only, Mfd by: Emcure Pharmaceuticals Ltd., Hinjawadi, Pune, India Mfg. for : Heritage Pharmaceuticals Inc. NDC 23155-0216-31
Published January 16, 2019 · Recall initiated: January 2, 2019
Summary
FDA records drug Class II recall D-0352-2019, published January 16, 2019 and initiated January 2, 2019. Recalling firm: Heritage Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 5,060 units; Lot: Lot #: VCIA082, Exp. MAY 2020; VCIA083, VCIA084, Exp. JUNE 2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: complaints received about dried powder on the outside of bottle
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Heritage Pharmaceuticals, Inc.
- Distributor
- Nationwide
- Lot
- Lot #: VCIA082, Exp. MAY 2020; VCIA083, VCIA084, Exp. JUNE 2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAMIKACIN SULFATE INJECTION, USP, 1 gram/4 mL (250 mg/ml), 4 mL vial, Rx only, Mfd. by: Emcure Pharmaceuticals,June 19, 2019
- FDALosartan Potassium Tablets USP 100 mg 90 film coated tablets Manufactured by: Vivimed Life Sciences PrivateMay 29, 2019
- FDAEstradiol Vaginal Inserts, USP, 10 mcg, Rx only, packaged in a) 8 count (NDC 68462-711-71) and b) 18 countJanuary 16, 2019
- FDACeftriaxone for Injection USP, 250 mg, packaged in a) one Single Use Vial (NDC 68180-611-01) and b) 10 SingleJanuary 16, 2019
- FDAEnamelast Cool Mint/OT Varnish 5% NaF Mint Label Enamelast Unit Dose 200pk Cool Mint: Enamelast 5% SodiumJanuary 9, 2019
- FDACidofovir injection 375 mg/mL (75 mg/mL) vial Injection, 5 mL vials, Rx Only, Mfg. By Emcure PharmaceuticalOctober 31, 2018
Questions about this recall
Was Cidofovir Injection 375mg/5mL (75mg/mL) vial injection. 5 mL vials, Rx only, Mfd by: Emcure Pharmaceuticals Ltd., Hinjawadi, Pune, India Mfg. for : Heritage Pharmaceuticals Inc. NDC 23155-0216-31 recalled?
Yes. FDA published recall D-0352-2019 on January 16, 2019. Reported hazard: Lack of Assurance of Sterility: complaints received about dried powder on the outside of bottle
What should I do if I have this product?
Voluntary: Firm initiated · Letter